Want to join the conversation?
$LH's net cash provided by operating activities for 2015 increased to $982.4MM from $739MM in the previous year. This increase was due primarily to additional cash generated by Covance Drug Development (CDD) operations following the Acquisition as well as improved working capital.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.